cbdMD (YCBD) FCF Payout Ratio (2017 - 2023)

cbdMD (YCBD) posted FCF Payout Ratio of 3.44 for Q4 2023, down 18.05% sequentially from 2.92 in Q2 2023, and down 671.64% YoY from 0.6 in Q4 2022.

cbdMD (YCBD) FCF Payout Ratio (2017 - 2023) Analysis & Trends

cbdMD has reported FCF Payout Ratio for 6 years, with the latest figure at 3.44 in Q4 2023.

Quarterly FCF Payout Ratio fell 671.64% year-over-year to 3.44 in Q4 2023, while the trailing twelve-month figure through Dec 2023 was 1.51 (down 360.58% YoY) and the FY2021 annual result came in at 0.18, down 478.13% from the prior year.
FCF Payout Ratio slipped to 3.44 in Q4 2023 per YCBD's latest filing, from 2.92 in the prior quarter.
Over five years, FCF Payout Ratio peaked at 0.69 in Q3 2020 and troughed at 3.44 in Q4 2023.
A 5-year average of 0.55 and a median of 0.18 in 2021 frame the typical range for FCF Payout Ratio.
The sharpest annual moves came in 2021 and 2022: FCF Payout Ratio tumbled 898.95% in 2021, then decreased 3.31% in 2022.
Over 5 years, FCF Payout Ratio stood at 0.01 in 2019, then plunged by 256.17% to 0.04 in 2020, then plunged by 300.97% to 0.18 in 2021, then tumbled by 154.25% to 0.45 in 2022, then slumped by 671.64% to 3.44 in 2023.
According to Business Quant data, FCF Payout Ratio over the past three periods registered 3.44, 2.92, and 0.61 for Q4 2023, Q2 2023, and Q1 2023 respectively.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	FCF Cover (Qtr)
1	Haleon	44.51 Bn	43.55 Bn	-	-
2	Teva Pharmaceutical Industries	43.52 Bn	39.86 Bn	2.15 Bn	-
3	Zoetis	32.43 Bn	30.75 Bn	1.05 Bn	0.41
4	Takeda Pharmaceutical	28.63 Bn	22.83 Bn	5.10 Bn	-0.83
5	United Therapeutics	21.87 Bn	19.21 Bn	683.80 Mn	-
6	Viatris	18.98 Bn	18.09 Bn	1.46 Bn	0.42
7	Neurocrine Biosciences	15.43 Bn	15.04 Bn	935.80 Mn	-
8	Elanco Animal Health	12.02 Bn	11.49 Bn	798.00 Mn	-
9	Dr Reddys Laboratories	10.14 Bn	9.98 Bn	-	-
10	cbdMD	5.41 Mn	3.29 Mn	3.04 Mn	-

Download Data